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Introduction {#sec001}
============

*Schistosoma mansoni* is a helminth parasite that causes schistosomiasis, a disease affecting about 200 million people in 56 countries. *S*. *mansoni* presents a heteroxenic life cycle, reproducing asexually inside *Biomphalaria* snails and sexually in mammals such as humans and rodents. Adult worms mate actively in the hepatic portal system and, subsequently, females will initiate egg production and release. Most of the eggs remain trapped in different organs of the definitive host, such as the liver, provoking inflammatory response and hepatic fibrosis. Nevertheless, some eggs reach the gut lumen and are liberated mingled with stool \[[@pntd.0008080.ref001]--[@pntd.0008080.ref003]\].

Oviposition, granuloma size, and cytokine and interleukin types can be modulated depending on the host profile, and variation in the aggressiveness of infection may be related to adaptation mechanisms of the parasite to the immunological environment in which it is found. Experimental infections in C57BL/6 mice (*Mus musculus*) generate immunological responses with greater intensity of interleukin IL10 and lower intensity of interleukins IL4 and IL13 when compared with infections in Balb/c mice \[[@pntd.0008080.ref004]\]. Granulomas from rodent infections from natural reservoirs are less aggressive in the liver and more aggressive in the intestine; the composition of the granuloma in these animals is characterized by the presence of extracellular matrix and fewer inflammatory cells \[[@pntd.0008080.ref005]\]. In contrast, Swiss strains infected with *S*. *mansoni* exhibit granulomas with extensive inflammatory infiltrates, often involving several eggs and the presence of necrosis \[[@pntd.0008080.ref005]\].

Immunological approaches using *WSX*^*-/-*^ mice (receptor chain of IL27) point to a reduction in IFN-γ levels compared with wild-type mice during acute and chronic stages of mansonic schistosomiasis but with no impact on liver damage \[[@pntd.0008080.ref006]\]. EBi3 is a subunit of interleukin-27 (IL27); in this case combined with p28 forming a heterodimer, as well as interleukin-35, in which it also forms a heterodimer associating with p35. IL27 promotes the activation of Th1 by induction of IFN-γ expression, but induct T regulatory functions through IL10 signaling. IL35 activates regulatory T cells, acting in an opposite manner to the interleukins IL12 and IL23 of the same family, and is expressed only through molecules that promote the transcription of its gene, these two interleukins conducts regulatory functions mainly \[[@pntd.0008080.ref007]\].

Epigenetics comprises changes in chromatin that do not involve changes in nucleotide sequence. These changes are triggered by environmental factors such as diet, social interaction, physical exercise, disease contagion, age, among others. Among the epigenetic alterations we can mention modifications in the N-terminal portion of the histone tail (acetylation, deacetylation, ubiquitination, deubiquitination, methylation, demethylation, among others), DNA modifications, such as methylation and demethylation of cytosines, regulation by microRNAs and Long non-coding RNAs. These changes are fundamental for gene expression regulation, sex X chromosome silencing in females, transposon silencing \[[@pntd.0008080.ref008],[@pntd.0008080.ref009]\]. Diseases that affect the liver causing collagen deposition induct alterations in the expression of DNA methyltransferases and DNA demethylases, leading to disturbance in expression of several genes \[[@pntd.0008080.ref010],[@pntd.0008080.ref011]\], here we intended evaluate in schistosomiasis. *DNMT1* enzyme is related to the maintenance of existing methylation during the replication process, copying the patterns from the template to the new strand, and is more expressed in the period before mitosis. DNMT3A and B are enzymes that lead by stimulus create new methylation patterns in DNA, they are *de novo* methyltransferases \[[@pntd.0008080.ref012]\]. TET1, 2 and 3 act synergistically and procedurally by removing 5-mC, the first step for 5-hydroxymethylcytosine (5-hmC), and following 5-formylcytosine (5-fC), 5-carboxycytosine (5-caC) and then return to usual cytosine \[[@pntd.0008080.ref013]\].

As different intensities of interleukins are detected during schistosomiasis depending on mouse lineage, immunological profile might induce alterations in the signaling pathways of worms allowing adaptation to the host. The presence of different epigenetic marks and changes in the patterns of these marks are involved in the transition of the evolutionary stages of *S*. *mansoni* and host--parasite interaction; H3K4me3 and H3K27me3 show greater variation and influence in the transformation of the parasite among phases \[[@pntd.0008080.ref014],[@pntd.0008080.ref015]\]. Epigenator molecules native to intracellular parasites such as protozoa trigger into host new metabolic pathways or interfere inducing initiator host proteins to modify metabolism and promote an environment suitable for parasite reproduction \[[@pntd.0008080.ref016]\]. Initiator host proteins rely mainly on alteration in transcription of cytokines, chemokines, proteins related to cell proliferation and apoptosis, and changes in the immunological setting \[[@pntd.0008080.ref016]\], and the intracellular parasite *Leishmania donovani* has been observed to induce methylation in host macrophage DNA \[[@pntd.0008080.ref017]\].

Aiming highlight some impact of immune system on epigenetic of *S*. *mansoni*, we explored the gene expression involved in chromatin modifications. Among these genes, *SmGCN5* is a histone acetyltransferase that targets histone N-terminal tail lysine residues. *S*. *mansoni* ortholog presents HAT and bromodomain, which also occurs in *Homo sapiens* and other species orthologs compared by the authors, *SmGCN5* associates with nuclear receptors, and has high expression rates throughout *S*. *mansoni* life cycle \[[@pntd.0008080.ref018]\]. HDACs enzymes remove the acetyl group from histones, conducting to gene silencing; *S*. *mansoni* has HDAC1, 3 and 8 and are expressed at all stages of the life cycle. HDAC8 has amino acid insertions that differ from HDACs present in the definitive host, so it has already been proposed as a target for inhibitors to implement new treatments in the future, according to these reports, HDAC8 shows both nuclear and cytoplasmic cellular localization \[[@pntd.0008080.ref019]\]. MBD methyl CpG binding domain is a protein that binds to methylated cytosines, and *S*. *mansoni* expressed it at all stages of the parasite\'s life cycle including both sexes. In the same approach the authors found that this protein has nuclear localization only and relates to oviposition \[[@pntd.0008080.ref020]\]. Previous studies identified 17 USP orthologs in *S*. *mansoni*, by homology with 56 USPs present in *H*. *sapiens*, it was detected that the expression of these USPs is altered in stages of egg, cercariae, schistosomula and adult worms, reflecting a recycling of proteins used by the parasite during the evolutionary stage transition \[[@pntd.0008080.ref021]\]. USPs can prevent different forms of degradation, i.e. proteasome \[[@pntd.0008080.ref009]\], lysosomal \[[@pntd.0008080.ref022]\], that are signaled by lysine ubiquitination. USPs also act on transcriptional regulation, since many USPs target histones, ubiquitinated histones may indicate chromatin activation or repression depending on histone variant and K residue \[[@pntd.0008080.ref009]\]. Substrate deubiquitination competes with ubiquitination and can reverse substrate fate and recycle polyubiquitinated conjugate chains. The position of the lysine to be ubiquitinated is directly related to the type of signaling generated \[[@pntd.0008080.ref009]\]. In this work USPs 7, 15, 22, 46 and 49 were selected among others because they have histones as a common target, potential epigenetic function in *S*. *mansoni*.

We hypothesize that *S*. *mansoni* reprogram gene expression in response to the immune system of the mammalian host, in this case C57BL/6 *EBi3*^*-/-*^ and alters the number of eggs produced. In response, mammalian host alters DNA methylation profile of hepatocytes by changing expression levels of DNMTs, TETs and the percentage of 5-mC and also modulates the extent of hepatic granuloma. Results presented in this work indicate that some parasitological parameters such as: number of eggs per gram of liver, number of hepatic granulomas, granuloma volume and number of eggs per gram of feces, are altered in the infected knockout model leading to epigenetic changes in mice and worms. To investigate the epigenetic interactions between *S*. *mansoni* and the mammalian host, the present work consists of three strands: (1°) the investigation of the parasitological effects of the C57BL/6 *EBi3*^*-/-*^ model (quantification of eggs trapped on tissues and feces and parasites); (2°) if the parasite would modulate epigenetic mechanisms in the host (expression analysis of DNMT and TETs, % 5-mC and miRNAs in liver) and (3°) if the host could affect the expression of genes related to parasite epigenetic mechanisms (expression of several genes related to epigenetic modifications in *S*. *mansoni* and some miRNAs).

Results {#sec002}
=======

*EBi3*^*-/-*^ influence on parasitological parameters {#sec003}
-----------------------------------------------------

*S*. *mansoni* parasite load in experimentally infected wild-type mice and *EBi3*^*-/-*^ mice was estimated by quantifying adult worms recovered by perfusion of the hepatic portal system and by counting eggs retained in the intestine, liver and feces. A mean of 480.9 ± 107.5 eggs per gram of intestine were quantified in *EBi3*^*-/-*^I mice compared with 526.3 ± 72.26 eggs per gram of intestine in WTI mice ([Fig 1A](#pntd.0008080.g001){ref-type="fig"}). Although the number of eggs aggregated in the intestines of WTI mice was greater than that in *EBi3*^*-/-*^I mice, this difference was not significant. By contrast, *EBi3*^*-/-*^I mice had significantly fewer eggs aggregated in the liver than WTI mice (2735 ± 413.6 vs. 8178 ± 1310 eggs per gram of liver, respectively, p = 0.0029) ([Fig 1B](#pntd.0008080.g001){ref-type="fig"}).

![Parasitological parameters of infected *EBi3*^*-/-*^ and WT mice.\
All mice were males, they had 17 g and 5 weeks old when were infected. The mean or median profile, depending on the test used, for 10 WTI mice and 15 *EBi3*^*-/-*^I mice of the first perfusion are represented, all statistical analysis used \* p \< 0.05. **(A)** Number of eggs recovered from the gut by digestion with KOH; (**B)** number of eggs recovered from the liver, p = 0.0029; (**C)** number of individual parasites recovered by perfusion of the hepatic portal system; (**D)** number of worm couples recovered; *t* test, \* p \< 0.05. (**E)** Number of hepatic granulomas found in 20 fields at ×20 magnification; Mann--Whitney test, p \< 0.0001. (**F)** Volume of granulomas; *t* test, p = 0.0001. (**G)** Number of eggs recovered from feces; *t* test, p \< 0.0001; GraphPad Prism 6. Error bars show the standard deviation.](pntd.0008080.g001){#pntd.0008080.g001}

A total of 100 cercariae were inoculated per mouse; a mean of 19.96 ± 2.051 worms were recovered from *EBi3*^*-/-*^ mice and 19.33 ± 2.726 from WTI mice. No statistical difference was observed in the recovery of worms between experimental groups ([Fig 1C](#pntd.0008080.g001){ref-type="fig"}). Coupled worms were also quantified, but no difference was detected between *EBi3*^*-/-*^I (4.826 ± 0.8906) and WTI (6.833 ± 1.256) mice ([Fig 1D](#pntd.0008080.g001){ref-type="fig"}).

The number of granulomas in livers of WTI mice (median = 57.5) was significantly higher than that in *EBi3*^*-/-*^I mice (median = 22), with p = 0.0001 ([Fig 1E](#pntd.0008080.g001){ref-type="fig"}). Granuloma volume was also higher in WTI mice than in *EBi3*^*-/-*^I mice, with p \< 0.0001 ([Fig 1F](#pntd.0008080.g001){ref-type="fig"}). Hepatic damage was greater in the presence of the immune response involving EBi3. Comparing the appearance of WTI and *EBi3*^*-/-*^I granulomas revealed that granulomas in knockout mice were frequently diffuse and disorganized. In WTI animals, granulomas were concentric, with greater presence of extracellular matrix and abundant fusions between granulomas (see microscopy in [S1 Fig](#pntd.0008080.s001){ref-type="supplementary-material"}). Egg numbers in feces were augmented significantly in WTI mice compared with *EBi3*^*-/-*^I mice (135.8 ± 9.181 vs. 17.76 ± 5.938 eggs per gram, p\<0.0001) ([Fig 1G](#pntd.0008080.g001){ref-type="fig"}).

Changes in *de novo* DNA methyltransferase and DNA demethylase expression in *EBi3*^*-/-*^ liver linked to *S*. *mansoni* infection evidenced by qRT-PCR {#sec004}
--------------------------------------------------------------------------------------------------------------------------------------------------------

In this work we evaluated the expression of maintenance and de novo DNA methyltransferases, as well as DNA demethylases in liver mice, in order to detect if the immune background would affect the expression of these enzymes and consequently the methylation patterns in DNA conducting to gene repression or activation. Gene expression was quantified using the *HPRT1* gene as calibrator, there was no statistical difference in *DNMT1* expression among WTC, WTI, *EBi3*^*-/-*^C and *EBi3*^*-/-*^I mice, with low levels of expression in all groups ([Fig 2A](#pntd.0008080.g002){ref-type="fig"}). WTC and WTI showed differences in *DNMT3A* expression, however, which was lost in the knockout model ([Fig 2B](#pntd.0008080.g002){ref-type="fig"}).

![Relative expression (qRT-PCR) of DNA methyltransferases and demethylases.\
**(A)** *DNMT1*, p = 0.0348 (**B)** *DNMT3A*, p = 0.0008 (**C)** *DNMT3B*, p = 0.0001 (**D)** *TET1*, p = 0.0041 (**E)** *TET2*, p = 0.0001 (**F)** *TET3*, p = 0.0001, in wild-type control (WTC n = 12) and infected mice (WTI n = 10), and control (*EBi3*^*-/-*^C n = 10) and infected (*EBi3*^*-/-*^I n = 28) knockout mice. Kruskal--Wallis, p \< 0.05; GraphPad Prism6. Comparisons indicated by the following letters are significant. a: WTC vs. WTI; b: WTC vs. *EBi3*^*-/-*^C; c: WTC vs. *EBi3*^*-/-*^I; d: WTI vs. *EBi3*^*-/-*^C; e: WTI vs. *EBi3*^*-/-*^I; f: *EBi3*^*-/-*^C vs. *EBi3*^*-/-*^I. **(G--H)** Spearman correlations: gene expression level for each *EBi3*^*-/-*^I mouse was correlated with granuloma number for the same mouse, all correlations were tested using p \< 0.05. **(G)** *DNMT1* expression level and granuloma number (p \< 0.0001; r = -0.3302); **(H)** *TET3* expression level and granuloma number (p = 0.0415; r = - 0.475). Error bars represents standard deviation. Dots in all graphs represent a mouse, totalizing 60 mice of all groups.](pntd.0008080.g002){#pntd.0008080.g002}

A similar pattern was observed for *TET1* demethylase, with a significance difference in expression only observed between WTC and WTI ([Fig 2D](#pntd.0008080.g002){ref-type="fig"}). Expression levels of the *DNMT3B* gene were affected by *S*. *mansoni* infection in knockout mice, as evidenced by differences in expression between *EBi3*^*-/-*^C and *EBi3*^*-/-*^I ([Fig 2C](#pntd.0008080.g002){ref-type="fig"}). There was a statistically significant decline in *DNMT3B* expression in *EBi3*^*-/-*^I compared to WTI. Expression levels of *TET2* showed differences between the wild-type control and the knockout control, but differences in demethylase expression did not prevail after *S*. *mansoni* infection ([Fig 2E](#pntd.0008080.g002){ref-type="fig"}). The *TET3* demethylase gene showed the highest levels of expression, with the difference between the controls also observed among infected mice, indicating little impact of *S*. *mansoni* infection on expression of this gene ([Fig 2F](#pntd.0008080.g002){ref-type="fig"}).

Correlation analysis among the expression of *TET1*, *2* and *3* and *DNMT1*, *3A* and *3B* indicated that there was a negative correlation between *DNMT1* and *TET3* gene expression and granuloma number in *EBi3*^*-/-*^I ([Fig 2G--2H](#pntd.0008080.g002){ref-type="fig"}). Liver damage induced downregulation of *DNMT1* and *TET3* expression considering granulomas number. Expression levels of the *DNMT3A*, *B* and *TET1* and *2* genes did not correlate with number and volume of granulomas.

Demethylation was more active than DNA methylation in wild-type and knockout mice considering the relative expression levels of TET and DNMT genes. The expression levels of *DNMT1* were different from those of all demethylases, while the expression levels of *TET2* and *TET3* were different from those of each DNA methyltransferase in control wild-type mice, as shown in [S2A Fig](#pntd.0008080.s002){ref-type="supplementary-material"}. *S*. *mansoni* infection produced maintenance of *TET1* and *DNMT1* expression levels and upregulation of *DNMT3A* and *B* expression levels in wild-type mice, resulting in levels similar to those of *TET2* and *3*; schistosomiasis induced high levels of methylation in infected wild-type mice compared with control wild-type mice as shown in [S2B Fig](#pntd.0008080.s002){ref-type="supplementary-material"}. The DNA methyltransferase transcriptional activation provoked by *S*. *mansoni* in wild-type mice was reversed in *EBi3*^*-/-*^I mice; expression levels of *TET1*, *2* and *3* were raised while those of DNMTs dropped substantially in *EBi3*^*-/-*^I mice compared with those in *EBi3*^*-/-*^C mice. *S*. *mansoni* induced differences between *DNMT1* and *3A* expression levels in *EBi3*^*-/-*^I livers, as shown in [S2C and S2D Fig](#pntd.0008080.s002){ref-type="supplementary-material"}.

Schistosomiasis increases % 5-mC of hepatic DNA in *EBi3*^*-/-*^ mice {#sec005}
---------------------------------------------------------------------

In DNA, 5-methylcytosine content quantified by Elisa assays using anti-5-methylcytosine revealed methylation contents of at least 0.5% of 5-mC. Knockout mice had statistically naturally higher percentages of % 5-mC in relation to wild-type mice in the liver (*EBi3*^*-/-*^C vs. WTC, p \< 0.05) *EBi3*^*-/-*^C had 1.58 times more of % 5-mC than WTC; this difference was lost (*EBi3*^*-/-*^I vs. WTI, p \< 0.05). *S*. *mansoni* infection reduced % 5-mC of hepatic DNA rates significantly in *EBi3*^*-/-*^I mice (p\<0.05) but not in WTI mice ([Fig 3](#pntd.0008080.g003){ref-type="fig"}), *EBi3*^*-/-*^C mice contained 1.96 times more of % 5-mC than *EBi3*^*-/-*^I. The reduced levels of % 5-mC DNA in livers of *EBi3*^*-/-*^I mice compared to *EBi3*^*-/-*^C mice ([Fig 3](#pntd.0008080.g003){ref-type="fig"}) was supported by the increase in *TET* expression levels presented in [S2D Fig](#pntd.0008080.s002){ref-type="supplementary-material"}.

![Methylation content of mouse liver DNA (% 5-mC).\
The figure represents the percentage of DNA 5-mC for the first perfusion mice. Error bars represents standard deviation of WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 5) and *EBi3*^*-/-*^I (n = 15) groups, each mouse had a technical duplicate of the biological sample using One-way ANOVA, p \< 0.05. \*: WTC vs. *EBi3*^*-/-*^C; \*\*: *EBi3*^*-/-*^C vs. *EBi3*^*-/-*^I; p = 0.0004.](pntd.0008080.g003){#pntd.0008080.g003}

*S*. *mansoni* miRNAs are modulated by the mouse immune system {#sec006}
--------------------------------------------------------------

MiRNAs important to liver metabolism as miR-122 and to fibrosis process as miR-31 were tested in this work to verify possible alterations caused by immune response coupled with infection. No statistical difference was observed in the fold change of miR-122-3p, miR-122-5p, or miR-31-3p and miR-31-5p levels between infected and control C57BL/6 *EBi3*^*-/-*^. This suggests that the liver damage caused in knockout mice may not produce alterations in release of this miRNAs ([Fig 4A--4D](#pntd.0008080.g004){ref-type="fig"}).

![Relative expression of miRNAs.\
Relative expression of **(A)** miR-31-3p, **(B)** miR-31-5p, **(C)** miR-122-3p and **(D)** miR-122-5p levels between livers of infected and uninfected C57BL/6 *EBi3*^*-/-*^ mice based on RT-qPCR. Small nuclear RNA U6 (SnU6) was used for calibration. Mann--Whitney U tests were performed; \*p \< 0.05. Dots in graphs relative to mice miRNAs represent a individual mouse **(E--H)** Fold change of miRNAs in *S*. *mansoni* males and females recovered from infected and uninfected C57BL/6 *EBi3*^*-/-*^ mice and infected and uninfected C57BL/6 WT mice based on RT-qPCR and Unpaired T with Welch's correction, \*p \< 0.01 were performed. Error bars represents standard deviation: **(E)** miR-124-3p, **(F)** miR-125-3p and miR125A, **(G)** miR-190-3p (p = 0.0055) and **(H)** miR-190-5p (p = 0.0033).](pntd.0008080.g004){#pntd.0008080.g004}

MiRNAs from *S*. *mansoni* were analyzed also to verify if the mouse immune system would affect the expression of these regulatory molecules in the parasite. Males and females worms recovered from WTI were used as control group and males and females worms recovered from *EBi3*^*-/-*^I were used as test group. Male and female *S*. *mansoni* worms taken from knockout mice expressed less miR-124-3p ([Fig 4E](#pntd.0008080.g004){ref-type="fig"}) than those retrieved from wild-type mice. miR-125A and miR-125-3p showed expression only in females ([Fig 4F](#pntd.0008080.g004){ref-type="fig"}). Males from knockout mice had higher expression levels of miR-190-3p and miR-190-5p ([Fig 4G and 4H](#pntd.0008080.g004){ref-type="fig"}) than males recovered from wild-type mice; however, in females the opposite occurred, with females recovered from wild-type animals showing higher expression of miR-190-3p and 5p than females recovered from knockout animals. miR-190-3p and 5p probably have sex-specific functions because their expression levels in *EBi3*^*-/-*^ mice showed statistically significant differences between males and females.

Spearman matrix correlation compared the parameters, (such as parasitological, DNA 5-mC %, expression of some genes and miRNAs, among others) of each mouse to each other to observe the influence of the parameters analyzed over them. The expression parameter of *TET2* correlated best with the others in the WTC group, considering p \<0.05%. TET2 was positively correlated with *TET3*, miR31-3p and miR122-3p. In addition, TET3 expression correlated positively with DNMT3A expression and miR31-3p also positively correlated with miR122-3p, as shown in [S1 Table](#pntd.0008080.s004){ref-type="supplementary-material"}.

In WTI group, *DNMT1* expression correlated positively with eggs in feces, miR122-5p expression correlated negatively with *DNMT3B* and positively with number of eggs in the intestine. Also, eggs in the liver and intestine correlated positively with each other, as shown in [S1 Table](#pntd.0008080.s004){ref-type="supplementary-material"}.

*EBi3*^*-/-*^C group presented the lowest number of correlations between the parameters considering the four groups analyzed. In this group *TET2* expression correlated positively with TET3 expression. *DNMT1* expression correlated positively with the liver\'s DNA 5-mC % content and miR122-3p expression as shown in [S1 Table](#pntd.0008080.s004){ref-type="supplementary-material"}. *EBi3*^*-/-*^I group was the group that presented the highest number of correlations between the parameters. The *TET1* gene expression correlated negatively with DNMT1 gene expression. TET3 correlated positively with TET2, DNMT1, and negatively correlated with granulomas number and miR31-3p and 122-3p expression. DNMT1 expression correlated positively with eggs in feces and negatively correlated with miR31-5p and 122-3p expression. Granulomas volume correlated positively with the number of eggs in the feces. The number of eggs in the intestine correlated positively with the number of granulomas found in the liver. MiR122-3p correlated positively with the number of granulomas found in the liver and miR122-5p expression as shown in [S1 Table](#pntd.0008080.s004){ref-type="supplementary-material"}.

Livers of infected *EBi3*^*-/-*^ mice harbor native *Schistosoma* lncRNAs {#sec007}
-------------------------------------------------------------------------

All lncRNAs presented in [Table 1](#pntd.0008080.t001){ref-type="table"} were quantified by their relative expression in the livers of infected and uninfected mice. These lncRNAs are found in *S*. *mansoni*, and detecting their presence in the livers of infected mice may aid in the development of new biomarkers for schistosomiasis. *LncRNAs 5*, *6*, *8* and *9* ([Fig 5](#pntd.0008080.g005){ref-type="fig"}) (neighboring beta-proteasome subunit 1, U3 nucleolar ribonucleoprotein and growth factor receptor of fibroblasts, actin suppressor (sac) and rRNA) had the highest relative expression in *EBi3*^*-/-*^I mice \[[@pntd.0008080.ref023]\]. LncRNAs not shown in [Fig 5](#pntd.0008080.g005){ref-type="fig"} were not expressed in the livers of infected mice or were expressed in both infected and uninfected mice.

![Relative expression of *S*. *mansoni* lncRNAs in the livers of C57BL/6 *EBi3*^*-/-*^I mice by RT-qPCR.\
All lncRNAs detected in schistosomula, cercariae and eggs were also evaluated in the liver, but lncRNAs with very low or undetectable expression levels are not shown in the figure. *Mus musculus* (mmu)-hypoxanthine-guanine phosphoribosyltransferase (*HPRT*) was used for calibration. Error bars show the standard deviation.](pntd.0008080.g005){#pntd.0008080.g005}
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###### Oligonucleotides used to evaluate *S*. *mansoni* gene expression.

![](pntd.0008080.t001){#pntd.0008080.t001g}

  --------------------------------------------------------------------------------------------
  Oligonucleotide              Sequence                           Source
  ---------------------------- ---------------------------------- ----------------------------
  ***SmMBD*** Gene DB\         F: 5'-CGGTTATTGTACGTTCTCATCC-3'\   \[[@pntd.0008080.ref051]\]
  Smp_138180                   R: 5'-CAGCACTCTGTATTCCTTTAGGC-3'   

  ***SmGCN5*** Gene DB\        F: 5'-GTGCAATGCAAATGGTTGAC-3'\     \[[@pntd.0008080.ref018]\]
  (Smp_070190)                 R: 5'-TTACGAAGGCGCTTCAAAAT-3'      

  ***SmHDAC1*** Gene DB\       F: 5'-GCGAGTATTTTCCCGGAACTG-3'\    \[[@pntd.0008080.ref019]\]
  (Smp_005210)                 R: 5'-CGCGACCTGCACCAATATCT-3'      

  ***SmHDAC3*** Gene DB\       F: 5'-TTTTACGATCCAGATTGTGGGA-3'\   \[[@pntd.0008080.ref019]\]
  (Smp_093280)                 R: 5'-CATGGGATGATTCGGTCCATA-3'     

  ***SmHDAC8*** Gene DB\       F: 5'-GGCATCAATGATTTGGACTGG-3'\    \[[@pntd.0008080.ref019]\]
  (Smp_091990)                 R: 5'-TCGGCTCCGCATTGAACTAC-3'      

  ***SmUSP 7*** Gene DB\       F: 5'-TTATGTCTCACCCGTCTC-3'\       \[[@pntd.0008080.ref021]\]
  (Smp_089180)                 R: 5'-CCCACTCTCTACAGAACAG-3'       

  ***SmUSP 15*** Gene DB\      F: 5'-TAGAACAAGAGCGTCCAC-3'\       \[[@pntd.0008080.ref021]\]
  (Smp_128770)                 R: 5'-GCAATCAGGGAGGCATAC-3'        

  ***SmUSP 22*** Gene DB\      F: 5'-CTGTAAATGGCTGCTCTG-3'\       \[[@pntd.0008080.ref021]\]
  (Smp_074400)                 R: 5'-ACGGGTGTATGGGTCAAC-3'        

  ***SmUSP 46*** Gene DB\      F: 5'-TCGGAGTAGATGCTGAAG-3'\       \[[@pntd.0008080.ref021]\]
  (Smp_000710)                 R: 5'-GGCACCTAGTTTCATTGG-3'        

  ***SmUSP 49/44*** Gene DB\   F: 5'-GGATTGGTGTGTTGTTCTTC-3'\     \[[@pntd.0008080.ref021]\]
  (Smp_123630)                 R: 5'-CGCATCTCCATCTTGTAG-3'        

  ***SmEIF4E***                F: 5'-TGTTCCAACCACGGTCTCG-3'\      \[[@pntd.0008080.ref052]\]
                               R: 5'-TCGCCTTCCAATGCTTAGG-3'       

  ***Sm-lncRNA 1***            F: 5'-AAGGGATGAGTTGACTGC-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-ACACGAAGACACCTATGACC-3'      

  ***Sm-lncRNA 2***            F: 5'-AGACAATGCGATGCCGTTAG-3'\     \[[@pntd.0008080.ref023]\]
                               R: 5'-TTTGGAACTCGTCAGCTAGG-3'      

  ***Sm-lncRNA 3***            F: 5'-TCACATCTCGCAACTCAG-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-AGTGGTCGTCAAGCAAAC-3'        

  ***Sm-lncRNA 4***            F: 5'-TTTCGACACGGCAACTGATC-3'\     \[[@pntd.0008080.ref023]\]
                               R: 5'-GCCGATTCAGTGTAGCAAAG-3'      

  ***Sm-lncRNA 5***            F: 5'-GATCGAGCTGTAACTGCAC-3'\      \[[@pntd.0008080.ref023]\]
                               R: 5'-GATCCACATCCATATGAGTG-3'      

  ***Sm-lncRNA 6***            F: 5'-GACTGTTGGAAGAGGAAATG-3'\     \[[@pntd.0008080.ref023]\]
                               R: 5'-GAGGATTTAAGCGACCATTG-3'      

  ***Sm-lncRNA 7***            F: 5'-CCGATGAGATGCGTATAG-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-GCAACACAGTGAGGTAGAG-3'       

  ***Sm-lncRNA 8***            F: 5'-CCACACAGGTAGTTCAGC-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-GAATCACTTGCACTTCGC-3'        

  ***Sm-lncRNA 9***            F: 5'-CTGTGAGAATGGTGGATG-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-ACGTTTATGAGCCGTAGC-3'        

  ***Sm-lncRNA 10***           F: 5'-GTGATATGCCCGGACAAAG-3'\      \[[@pntd.0008080.ref023]\]
                               R: 5'-TTGAACGAGCAGCTGGAC-3'        

  ***Sm-lncRNA 11***           F: 5'-CCTCGTGTTTGTGCTTTG-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-GGAATGTGATTGCCTAGTCG-3'      

  ***Sm-lncRNA 12***           F: 5'-GCACTTGACACTAACCAGG-3'\      \[[@pntd.0008080.ref023]\]
                               R: 5'-GGAGCTGTTCACTCATTG-3'        

  ***Sm-lncRNA 13***           F: 5'-TTCCCTCCAGACTATGATCC-3'\     \[[@pntd.0008080.ref023]\]
                               R: 5'-CACGTATTGCACCTGATG-3'        

  ***Sm-lncRNA 14***           F: 5'-GTTGAAGAAGGTGAGTGC-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-GTGGAGGACTTGGAGATAC-3'       

  ***Sm-lncRNA 15***           F: 5'-CCATGCAAGTGTGATCCG-3'\       \[[@pntd.0008080.ref023]\]
                               R: 5'-GTGGGATTATCAGCTGCAGG-3'      

  **LTR- Retrotransposon**\    F: 5'-GGGTGCATCAGAGTAATC-3'\       \[[@pntd.0008080.ref023]\]
  **Saci 4**                   R: 5'-ACTTGATCCGCATACTCC-3'        
  --------------------------------------------------------------------------------------------

The analysis of the presence of *S*. *mansoni* lncRNAs in *EBi3*^*-/-*^I mouse liver was made in order to select very preliminary possible biomarkers for schistosomiasis, if they did not also express in the control group. In this experiment samples from 5 *EBi3*^*-/-*^C and 13 *EBi3*^*-/-*^I were used. But to confirm lncRNAs as biomarkers, their detection in serum is necessary. Further experiments are needed to confirm that these lncRNAs are specific to *S*. *mansoni*.

Sets of *S*. *mansoni* genes disturbed by the host immune system {#sec008}
----------------------------------------------------------------

This work aimed also to detect whether genes related to epigenetic changes in *S*. *mansoni* are differentially regulated in parasites that developed in a different immune environment (wild-type versus knockout mouse). Genes encoding the histone deacetylase *SmHDAC3* and ubiquitin-specific proteases *SmUSP15* and *SmUSP49/44* showed no statistical difference in expression levels among the four groups, as shown in [S3 Fig](#pntd.0008080.s003){ref-type="supplementary-material"}. Sex-specific expression of the *SmMBD*, *SmUSP7*, *SmUSP22* and *SmHDAC8* genes was lost in worms isolated from *EBi3*^*-/-*^ mice; by contrast, expression of *SmUSP46* was maintained and *SmHDAC1* gained sex-specific expression compared with worms isolated from WT mice ([Fig 6](#pntd.0008080.g006){ref-type="fig"}). Male parasites recovered from knockout mice showed downregulation of *SmMBD*, and *SmUSP7*, *22* and *46* gene expression, whereas only expression of the *SmUSP7* gene was downregulated in the female parasites compared with those recovered from WT mice. Worms recovered from knockout mice only showed upregulation of *SmHDAC1* expression in females. Male parasites recovered from WT mice showed high expression levels of *SmGCN5* compared with female recovered from *EBi3*^*-/-*^ mice. Absence of the IL27 and IL35 pathways in *EBi3*^*-/-*^ knockout mice influenced both male and female worms to lower levels of transcription.

![Genes modulators of epigenetics: Expression in *S*. *mansoni*.\
**(A)** Histone acetyltransferase, *SmGCN5*, p = 0.0084; **(B)** methyl binding domain, *SmMBD*, p \< 0.0001; **(C)** histone deacetylase, *SmHDAC1*, p = 0.0002; and **(D)** *SmHDAC8*, p = 0.0027. Ubiquitin-specific protease expression in *S*. *mansoni*: **(E)** *SmUSP7*, p \< 0.0001 **(F)** *SmUSP22* p \< 0.0001, and **(G)** *SmUSP46*, p = 0.0087. Female and male LE represents parasites recovered from WT mice; female and male *EBi3*^*-/-*^ represent parasites recovered from knockout mice; all mice were infected with 100 cercariae. Experiments were performed in triplicate using a pool of at least 50 parasites per extraction. One-way ANOVA, p \< 0.01; GraphPad Prism 6. Comparisons indicated by the following symbols are significant. ϖ Female from *EBi3*^*-/-*^ vs. male from *EBi3*^*-/-*^. π Male from LE vs. male from *EBi3*^*-/-*^. δ Male from LE vs. female from *EBi3*^*-/-*^. ∞ Female from LE vs. male from *EBi3*^*-/-*^. Ԑ Female from LE vs. female from *EBi3*^*-/-*^. \* Female from LE vs. male from LE. Error bars show the standard deviation.](pntd.0008080.g006){#pntd.0008080.g006}

Analysis of the relative expression of *SmUSP7* to the calibrator gene *EIF4E* revealed that there is a difference between male and female controls, the male control worms is 3.4 times upregulated compared to the female control worms. There is a difference between the two groups of males, the recovered *EBi3*^*-/-*^I male worm is 6 times downregulated compared to the male control worms and between the two groups of females, the recovered *EBi3*^*-/-*^I female worm is 5 times downregulated compared to the female control worms.

Regarding the expression of *SmUSP22*, the male control worms is 4.6 times upregulated compared to the female control worms. The male recovered from *EBi3*^*-/-*^I is 7.2 times downregulated compared to the male control worms.

The USP gene that was most influenced by the host immune system in *S*. *mansoni* was *SmUSP46*. It was observed that male control worms were 2.6 times upregulated compared to female control worms. There was also a difference between the two groups of females; the female worms recovered from *EBi3*^*-/-*^I were 9.1 times downregulated compared to the control female. It was also possible to observe difference between the two groups of males; the male worms recovered from *EBi3*^*-/-*^I were 7.4 times downregulated compared to the control male. The recovered *EBi3*^*-/-*^I male was 3.2 times upregulated compared to the recovered *EBi3*^*-/-*^I female.

*SmGCN5* was differentially expressed between male control worms which were 24.4 times upregulated compared to the recovered *EBi3*^*-/-*^I female. Considering *SmMBD* expression, male control worms were upregulated 11.1 times compared to female control worms. The recovered male *EBi3*^*-/-*^I mouse was downregulated 7.7 times in relation to the control male. In the *SmHDAC1* gene the expression of the recovered *EBi3*^*-/-*^I female was 8.3 times downregulated compared to the recovered *EBi3*^*-/-*^I male. In the *SmHDAC8* gene male control worms were 9.3 times upregulated compared to female control worms.

Discussion {#sec009}
==========

At the beginning of the acute phase of schistosomiasis, the immune system of the definitive host aims mainly to attack the worms, initiating an intense Th1 response \[[@pntd.0008080.ref024]\]. Oviposition activates the Th2 immune response, which aims to destroy the eggs; this is beneficial for the host since the Th1 response causes greater liver damage \[[@pntd.0008080.ref025]\]. But induction of Th2 is also advantageous for the parasite, because it thus escapes the focus of the immune system. *S*. *mansoni* eggs produce and secrete a number of substances harmful to the liver, an example of which is the Omega 1 ribonuclease that is internalized by dendritic cells causing a decrease in the production of IL12, an important interleukin in the maintenance of Th1 \[[@pntd.0008080.ref026]\]. We experimentally infected wild-type mice and *EBi3*^*-/-*^ knockout mice, lacking functional IL27 and IL35 pathways, with *S*. *mansoni*. Similar numbers of parasites and pairs of parasites indicated that infection was equally efficient. However, the changes to the immunological background of mice induced a reduction in the number of eggs in feces and retained in the liver and also a reduction in granuloma number and volume.

Granulomas in *EBi3*^*-/-*^I mice seemed to be in the early stage, judging from their low quantity of extracellular matrix and predominance of disorganized inflammatory cells. Hepatic stellate cells (HSCs) are activated during the Th1 response, induced by secreted cytokines \[[@pntd.0008080.ref027]\]. Activated HSCs produce and secrete extracellular matrix, IL27 and IL35 are interleukins belonging to the Th1 response \[[@pntd.0008080.ref007],[@pntd.0008080.ref027]\]. In our knockout mice infected with *S*. *mansoni*, we observed predominately inflammatory cells in hepatic granuloma and few collagen fibers; this may have been due to the absence of the immune response performed by IL27 and IL35, then, the Th1 response in the liver might enhance the increase of fibrosis during infection by *S*. *mansoni*.

A previous study using a knockout model of the *WSX* chain of the IL27 receptor demonstrated a decrease in Th1 response-related cytokines without impacting changes in granuloma, using 80 cercariae of the Puerto Rican *S*. *mansoni* strain for infection \[[@pntd.0008080.ref006]\]. In our model, 100 cercariae of the LE strain were used, and the volume and number of granulomas were reduced in *EBi3*^*-/-*^ livers at the acute phase of schistosomiasis.

The DNA methylation and demethylation of liver affected by schistosomiasis remains unexplored. In our approach the S2 highlights the expression of all genes in each group facilitating the perception of patterns, for example, analyzing each group separately we can see tendencies to methylation of hepatic DNA during infection considering WTC versus WTI. *S*. *mansoni* infection led to an increase in DNA methylation in WTI mice, indicated by a decrease of statistical differences among relative expression levels of all *TET* and *DNMT* genes in the WTI group compared to statistical differences among *TET* and *DNMT* expression levels in WTC; comparing [Fig 2](#pntd.0008080.g002){ref-type="fig"} with S2 suggests that *DNMT3A* plays an important role in the rate changes observed. In *EBi3*^*-/-*^ mice, infection caused an increase in DNA demethylation and analyzing *EBi3*^*-/-*^C versus *EBi3*^*-/-*^I we can see that *TET1* plays the major differences observed in S2, but *TET2* and *TET3* also increased strongly their expression values. The literature lacks data about methylation and demethylation of DNA in hepatic tissues during schistosomiasis, but considering other disease that affect the liver causing collagen deposition, there is an increase in liver methylation during hepatic fibrosis development, as determined by analyzing the overall methylation and the methylation of specific genes (Septina9, Long non-coding RNA H19, SUN2) in diseases such as hepatocarcinoma, hepatitis and cirrhosis \[[@pntd.0008080.ref010],[@pntd.0008080.ref011],[@pntd.0008080.ref028]\], this occurred in our control groups WTC and WTI considering the qRT-PCR data.

MiRNAs are well explored in *S*. *mansoni* adult males and females have different repertoires or amounts of some miRNAs, many of which are important for the normal development of the parasite\'s reproductive organs in addition, these molecules are distributed for all chromosomes autosomal and sexual \[[@pntd.0008080.ref029]\]. Adult worms have miRNAs with some predicted targets located in the definitive host, reinforcing the role of these molecules in parasite-host interaction \[[@pntd.0008080.ref030]\]. A previous work of our group identified a set of miRNAs in silico highlighting their conservation in *S*. *mansoni* \[[@pntd.0008080.ref031]\]. Recently some miRNAs present in the work of our group cited before were found in *S*. *mansoni* exosomes from parasite culture medium and also in mice serum, bouncing their potential to act in host targets and to be involved in host-parasite interactions \[[@pntd.0008080.ref030]\]. Some of these miRNAs were tested in the experiments of this present work to detect if exists also alterations in miRNA expression influenced by immune response of the host, given its importance as possible biomarkers and interactions with the host. Our results showed statistical differences in expression of miR-190-3p and miR-190-5p between the fold change of males and females, reinforcing the importance of miRNAs for adaptation of the parasite to the host biased by sex and coupled to immune response of the host. The miR-125A and miR-125-3p were more expressed in females worms recovered from WTI than females recovered from *EBi3*^*-/-*^I mice, males worms recovered from *EBi3*^*-/-*^I mice did not expressed, and so it was not possible to perform fold change to this group.

MiR-122 has been analyzed in the mice livers because it inhibits targets that promote STAT3 phosphorylation, and it has also been reported that B and T cell differentiation increases in the presence of EBi3 through the gp130 and STAT3 receptors. MiR-122 inhibits STAT3 indirectly, and this receptor is part of the response generated by EBi3 \[[@pntd.0008080.ref032],[@pntd.0008080.ref033]\]. In this work it was observed that there is a negative correlation between this miRNA and the DNA methyltransferase and demethylase genes (*DNMT1* and *TET3*) and positive with the number of granulomas found in the liver of *EBi3*^*-/-*^I mice, which does not occur in WTI. This correlation was induced by knockout of the pathway, since this miRNA indirectly influences EBi3. In *EBi3*^*-/-*^C miR-122-3p also correlated with *DNMT1* expression, indicating that this association may be instrumental in the knockout model. In WTC miR-122-3p showed positive correlations with methylase and demethylase gene expressions (*DNMT3A* and *TET2*), the opposite occurred in infected knockouts and controls, no correlation was observed between miRNAs in the WTI group. The miRNAs that are part of the same pre-miRNA, miR-122-3p and 5p also correlated positively.

Of the *S*. *mansoni* USPs analyzed here, *SmUSP7* has the most domains, enabling the most functions, and this SmUSP therefore presents the highest level of expression independently of the strain \[[@pntd.0008080.ref021]\]. *USP7* orthologs have the ability to deubiquitinate histone acetyltransferase Tip60, which is involved in the acetylation of various histone H2A subtypes, deubiquitinate lysine 63 preventing the degradation of histone deacetylase Sirt7, and deubiquitinate histone H3 in a process involving the methylation of newly synthesized DNA by *DNMT1* \[[@pntd.0008080.ref034]--[@pntd.0008080.ref036]\]. In our study of *SmUSP7* expression, control male parasites showed relative expression levels of between 6 and 8 while control female parasites presented relative expression levels of approximately 2.

*SmUSP15* was expressed at minimal levels. This enzyme deubiquitinates TGFβ receptors, preventing their degradation, and is also involved in Smad deubiquitination, altering their cellular localization and signaling \[[@pntd.0008080.ref037]\]. *USP15* orthologs also promote H2B deubiquitination related to transcriptional activation \[[@pntd.0008080.ref038]\]. *SmUSP22* expression levels were reduced in parasites recovered from knockout animals in relation to those in control parasites; knockout mice immunological system influenced in males parasites expression conducting them to downregulation. USP22 participates in the SAGA transcriptional activating complex, and its downregulation might be related to chromatin repression \[[@pntd.0008080.ref039]\].

*SmUSP46* expression levels in parasites recovered from knockout animals were much lower than those in parasites recovered from wild-type mice, but proportional expression in males and females was similar. In other species, USP46 deubiquitinates deubiquitinate histones H2A and H2B associated to USP12 and WDR48 proteins, reinforcing its epigenetic function \[[@pntd.0008080.ref040]\]. The paralog *SmUSP49-44* showed no significant changes in expression level in parasites recovered from knockout or wild-type mice. In other species, the USP49-44 enzyme deubiquitinates H2B histones \[[@pntd.0008080.ref041]\]. Our results indicated that the host immune system does not cause changes in *SmUSP49-44* expression level.

*SmMBD* expression levels were lower in male parasites recovered from knockout animals than in those recovered from wild-type mice. This gene has been linked to normal egg production and number of eggs produced \[[@pntd.0008080.ref020]\], and our *EBi3*^*-/-*^I mice eliminated smaller quantities of eggs in feces. *SmMBD* forms part of the NuRD repression complex along with the HDAC8 enzyme \[[@pntd.0008080.ref042]\]. In our study, this machinery was downregulated in male parasites recovered from *EBi3*^*-/-*^I mice due to decreased *SmMBD* expression; *SmHDAC8* expression levels revealed only a loss of sex-specific function in worms recovered from *EBi3*^*-/-*^I mice. Motility and viability of schistosomula and adults may also be affected by the absence of histone deacetylase activity \[[@pntd.0008080.ref043]\]. *SmHDAC1* expression levels revealed a notable difference between females recovered from WT mice and females recovered from *EBi3*^*-/-*^ mice, and males and female parasites recovered from *EBi3*^*-/-*^I mice gained sex-specific functions. Epigenetic plasticity is also important for fertility maintenance in the parasite, as demonstrated by the inhibition of histone acetyltransferase genes and enzymes \[[@pntd.0008080.ref044]\]. The expression patterns of *SmHDAC3* did not vary under our experimental conditions.

Decreased oviposition and worm size has already been observed in other models of knockout, such as hepatic CD4 ^+^ T-lymphocyte^-/-^, in addition to decreased male-female pairing \[[@pntd.0008080.ref045]\]. More recent studies have detected that nematodes are stimulated by the induction of some interleukins. The presence of IL 5 increased nematode reproduction and parasites recovered from IL 5^-/-^ mice had larvae size smaller than the larvae size recovered from control, thus concluding that this interleukin promoted faster development and reproduction without altering other parasite characteristics \[[@pntd.0008080.ref046]\]. Our EBi3 knockout model may have induced decreased worm oviposition. It has been described that p28 and p35 generate signaling independent of EBi3 protein, but this signaling has unknown function and impact so far \[[@pntd.0008080.ref007]\]. In the study that assessed the impact of the WSX-1 knockout chain (the only receptor chain that is not shared with other interleukins besides IL27) the authors detected a decrease in IFNɣ \[[@pntd.0008080.ref006]\]. In this study, the absence of IL27 due to EBi3 knockout could also have triggered a decrease in IFNɣ and a decrease in granulomas volume, since this cytokine is important in the acute phase of schistosomiasis. The impact of IL35 should be more evident in the chronic phase of schistosomiasis mansoni, in which there is an increase in the regulatory immune response, since IL35 has a strong anti-inflammatory/regulatory function. The host reacted to this softer pattern of infection and modulated the expression of genes responsible for alterations in silencing and activation in DNA, which may interfere with the transcriptional regulation of several genes ([Fig 7](#pntd.0008080.g007){ref-type="fig"}).

![Effect of the mouse *EBi3*^*-/-*^ immune system on schistosomiasis.\
Comparative scheme of the main immune system impacts on parasite and host. The immune system can modulate gene and miRNA expression in worms and the quantity of eggs they release resulting in less hepatic damage. In definitive host the number of granulomas, eggs/g of feces, expression of *TET3* were reduced, besides the increasing the % 5-mC in liver DNA.](pntd.0008080.g007){#pntd.0008080.g007}

In this study we analyzed a set of genes related to histone modifications and miRNAs in *S*. *mansoni* and evaluated the parasitological profile of infected EBi3 knockout mice. Altered miRNAs during hepatic fibrosis, DNA methylation/demethylation genes that influence gene regulation and the overall 5-mC content were analyzed in the definitive host. With these analyzes it was possible to realize that the parasite behaves differently in response to the host immune system. Chromatin compaction/decompression genes are altered in *S*. *mansoni*, this reflected in the amount of eggs produced that were detected in the liver and feces of mice. As we analyzed the expression of epigenetic genes in *S*. *mansoni*, the observed differences are likely to influence the expression of other parasite genes. Cercariae exhibit significant survival variability depending on the mouse strain used and schistosomiasis vaccines have so far shown little effectiveness \[[@pntd.0008080.ref047]\]. Perhaps the ability of the parasite to adapt to the host immune system triggering a different infection profile as shown in this study is one of the factors that make this discovery difficult if we compare controls with knockouts.

Methods {#sec010}
=======

Ethics statement {#sec011}
----------------

The studies were approved by CEUA---FMRP--USP (Ethics Committee on Animal Use--Medical College of Ribeirão Preto--University of São Paulo) and are in accordance with Ethic and Animal Use Committee of the National Council for Control of Animal Experimentation---CONCEA-FMRP USP protocol no. 195/2015, law No. 11,794, of October 8, 2008. This protocol meets national and international standards of use and care. Knockout and wild mice were conditioned according to Quirino et al. \[[@pntd.0008080.ref048]\].

Parasites {#sec012}
---------

*S*. *mansoni* (LE strain) parasites recovered from infected C57BL/6 mice (WTI) and infected C57BL/6 *EBi3*^*-/-*^ mice (*EBi3*^*-/-*^I) were obtained by hepatic portal system perfusion of the animals, after 55 days of infection. Male and female parasites were counted and separated in plates and stored at -80°C ([Fig 8](#pntd.0008080.g008){ref-type="fig"}).

![Experimental scheme to compare molecular and parasitological parameters in mouse *EBi3*^*-/-*^ and WT infected with *S*. *mansoni* and their influence on the male and female parasites.\
Male mice *EBi3*^*-/-*^ and WT had 17 g and 5 weeks of life when they were infected and remained 55 days infected, and the uninfected groups *EBi3*^*-/-*^C and WTC waited the same time in the same conditions. During the euthanasia, feces of the last day were collected from the cages. The couple worms collected were mechanically separated by sex, counted and stored; the single worms were counted and stored too. Intestines weighting and identification allow collect data individually. The division of livers into four parts, identification of each mouse part and weighting in order to obtain data more precise.](pntd.0008080.g008){#pntd.0008080.g008}

Livers {#sec013}
------

Mice *EBi3*^*-/-*^ and WT had 17 g and 5 weeks of life when they were infected and remained 55 days infected, the uninfected groups *EBi3*^*-/-*^C and WTC waited the same time in the same conditions, only males were used for all experiments. When the mice were euthanized they had 13 weeks of life approximately. Livers from all mice were divided, left medial lobe for RNA extraction, left lateral lobe for parasitological tests (count of eggs if infected), right medial lobe for DNA extraction and right lateral lobe along with caudate process for microscopy. Thus, at the end of experiment was possible to have a result corresponding to each mouse separately. In this work were performed two perfusions, the first with 12 WTC, 10 WTI, 5 *EBi3*^*-/-*^C and 15 *EBi3*^*-/-*^I. The second perfusion were conducted only with knockout mice, 5 *EBi3*^*-/-*^C and 13 *EBi3*^*-/-*^I, to recover livers tissues to expression of lncRNAs, to increase the control knockout group and to rescue more worms. We did not acquire microscopic and parasitological parameter from the second perfusion. The correlations were analyzed using only the first perfusion data for infected mice, aiming to plot the parameters corresponding to a given mouse properly in a row, ([Fig 8](#pntd.0008080.g008){ref-type="fig"}).

Parasitological parameters {#sec014}
--------------------------

Feces obtained the night before euthanasia were homogenized of each mouse separately in phosphate buffer (PBS) containing 10% formaldehyde until the day of counting; aliquots of 100 μL were used for counting with the aid of light microscopy. After euthanasia, mouse liver and intestine were weighted and after incubated separately in 10% KOH solution for 16 h in 15 mL tubes. Subsequently, the digested organs were centrifuged at 200 *g* for 2 min, washed in 0.85% NaCl solution and stored at 4°C for counting; aliquots of 100 μL were used for counting with the aid of light microscopy.

After euthanasia of mice, one part of the liver was fixed in 1× PBS buffer supplemented with 10% formaldehyde for the preparation of hematoxylin and eosin-stained slides (HE); the slides were prepared in the NUPEB/UFOP Microscopy Multiuser Laboratory and examined using a Leica DM5000B microscope. Photodocumentation was established at a 20X magnification. The volume of granulomas was measured using granuloma radius in the ImageJ program (NHI), described in \[[@pntd.0008080.ref049]\]. Statistical significance was calculated by *t* test in Graph Pad Prism 6; p\<0.05 was considered significant.

*S*. *mansoni*: Expression of genes epigenetic modulators {#sec015}
---------------------------------------------------------

Male and female *S*. *mansoni* LE worms recovered from WTI and *EBi3*^*-/-*^I mice were used for RNA extraction. Pools containing 50 worms were homogenized in 700 μL Tri Reagent (Sigma Aldrich, San Luis, Missouri, USA) using a Polytron (3 pulses, 15 s). DNA was degraded by three independent rounds of digestion RNase-free DNase I, and a Promega SV total kit (Promega, Madison, Wisconsin, USA) was used to clean RNA according to the manufacturer's instructions. RNA was quantified using a Nano Drop spectrophotometer (Thermo Fischer Scientific, Carlsbad, CA, USA) and stored at -80°C. RNA integrity was evaluated in agarose/formaldehyde electrophoresis gels.

Aliquots containing 1 μg of total extracted RNA were used as template for first-strand cDNA synthesis (High Capacity RT-PCR System, Applied Biosystems), according to the manufacturer's recommendations in a thermocycler version 3.2 (Biocycler). cDNA was stored at -80°C.

cDNA (100 ng) was added to oligonucleotides (2.5 μM) and Power SYBR Green Master Mix (1X), and samples were transferred to 96-well plates for the qPCR reaction. Gene amplification was performed in an Applied Biosystems ABI7300. Ultrapure water and total RNA were used as negative controls. Relative gene expression was quantified by the 2^-ΔCq^ method using *EIF4E* as an endogenous control ([Table 1](#pntd.0008080.t001){ref-type="table"}) \[[@pntd.0008080.ref050]\]. All experiments were conducted in triplicate.

Expression of *de novo* and maintenance DNA methyltransferases, demethylases and long non-coding RNAs in infected and uninfected wild-type and knockout mice {#sec016}
------------------------------------------------------------------------------------------------------------------------------------------------------------

RNA was extracted from the livers of uninfected and infected C57BL/6 (WTC and WTI) and uninfected and infected C57BL/6 *EBi3*^*-/-*^ (*EBi3*^*-/-*^C and *EBi3*^*-/-*^I) mice. About 100--120 mg of tissue was homogenized with 1 mL of Tri Reagent (Sigma Aldrich) with the aid of a Polytron, using 3 pulses of 30 s, RNA was extracted using chloroform and precipitated with ethanol. DNA was degraded with DNAse Turbo (Thermo Fisher) as previously described, and a Promega SV total kit was used to clean RNA according to the manufacturer's instructions. RNA was quantified using a Nano Drop spectrophotometer (Thermo Fisher) and stored to -80°C. RNA integrity was evaluated in 1.2% agarose/formaldehyde electrophoresis gels. Total extracted RNA (1 μg) was used as template for first-strand cDNA synthesis (High Capacity RT-PCR System, Applied Biosystems), according to the manufacturer's recommendations using a thermocycler (Biocycler, version 3.2). cDNA (100 ng) was added to oligonucleotides (2.5 μM) and SYBR Green Select Master Mix. Ultrapure water and total RNA were used as negative controls. Relative gene expression was quantified by the 2^-ΔCq^ method using *HPRT* as an endogenous control ([Table 2](#pntd.0008080.t002){ref-type="table"}) \[[@pntd.0008080.ref050]\]. We had a tube of RNA and other of cDNA corresponding to a mouse, totalizing 60 tubes, each gene analyzed had a technical triplicate, and we did not ever used pools for mice experiments.

10.1371/journal.pntd.0008080.t002

###### Oligonucleotides used to evaluate gene expression in C57BL/6 mouse liver.

![](pntd.0008080.t002){#pntd.0008080.t002g}

  --------------------------------------------------------------------------------------------------------
  Oligonucleotides                      Sequence                              Source
  ------------------------------------- ------------------------------------- ----------------------------
  ***MmuHPRT*** GenBank (NC_000086.7)   F: 5'-TGACACTGGCAAAACAATGCA-3'\       \[[@pntd.0008080.ref053]\]
                                        R: 5'-GGTCCTTTTCACCAGCAAGCT-3'        

  ***MmuDNMT1*** GenBank\               F: 5'-CTACCTGGCTAAAGTCAAGTC3-'\       \[[@pntd.0008080.ref054]\]
  (NC_000075.6)                         R: 5'-CACTCTCTGTGTCTACAACTC-3'        

  ***MmuDNMT3A*** GenBank\              F: 5'-GCACCTATGGGCTGCTGCGAAGACG-3'\   \[[@pntd.0008080.ref054]\]
  (NC_000078.6)                         R: 5'-CTGCCTCCAATCACCAGGTCGAATG-3'    

  ***MmuDNMT3B*** GenBank\              F: 5'-CAAGGAGGGCGACAACCGTCCATT-3'\    \[[@pntd.0008080.ref054]\]
  (NC_000068.7)                         R: 5'-TGTTGGACACGTCCGTGTAGTGAG-3'     

  ***MmuTET1*** GenBank\                F: 5'-GAGCCTGTTCCTCGATGTGG-3'\        \[[@pntd.0008080.ref055]\]
  (NC_000076.6)                         R: 5'-CAAACCCACCTGAGGCTGTT-3'         

  ***MmuTET2*** GenBank\                F: 5'-AACCTGGCTACTGTCATTGCTCCA-3'\    \[[@pntd.0008080.ref054]\]
  (NC_000069.6)                         R: 5'-ATGTTCTGCTGGTCTCTGTGGGAA-3'     

  ***MmuTET3*** GenBank\                F: 5'-TCCGGATTGAGAAGGTCATC-3'\        \[[@pntd.0008080.ref054]\]
  (NC_000072.6)                         R: 5'-CCAGGCCAGGATCAAGATAA-3'         
  --------------------------------------------------------------------------------------------------------

Liver and *S*. *mansoni* miRNA expression {#sec017}
-----------------------------------------

miRNA extraction was conducted using 50 mg of liver from *EBi3*^*-/-*^C and *EBi3*^*-/-*^I mice or three replicates containing 50 male *S*. *mansoni* worms and three replicates containing 50 female worms. Extractions were performed using a miRNeasy kit (Qiagen) following the manufacturer's protocol in order to obtain a sample enriched with miRNAs. Each biological sample was homogenized in 700 μL QIAzol Lysis Reagent (Qiagen) with the aid of a Polytron-type homogenizer. Worm and liver samples were treated three times with Ambion DNAse Turbo (Thermo Fisher) to eliminate DNA contamination. After extraction, samples were quantified using a Thermo Fischer Nano Drop and the integrity of the samples was evaluated on 1.2% agarose/formaldehyde gel. Reverse transcription was performed using 1 μg of RNA with a miScript II cDNA (Qiagen) preparation kit RT for the evaluation of miRNA expression according to the manufacturer's recommendations. Gene expression was assayed using a miScript SYBR Green PCR kit for expression of liver miRNAs on an Applied Biosystems 7300 platform and quantified by the 2^-ΔCq^ method. Gene expression was assayed using a Taqman miRNA assay kit (Applied Biosystems, Foster, CA, USA) for expression of *S*. *mansoni* miRNAs on an Applied Biosystems 7500 platform and quantified by the 2^-ΔΔCq^ method. We conducted this experiment with parasite pools and as the expression of mice genes described before, we used 60 mice individually, 1 biological replicate for mouse for each analysis and three technical replicates to all miRNAs analyzed.

DNA 5-mC % content in mouse liver {#sec018}
---------------------------------

Liver genomic DNA from WTC, WTI, *EBi3*^*-/-*^C and *EBi3*^*-/-*^I mice was extracted from 30 mg of liver homogenized with liquid nitrogen in a crucible following the steps and reagents from the Wizard kit (Promega), this experiment were conducted with 42 mice, 1 biological replicate for each analysis from all groups of the first perfusion in technical duplicates. Samples were quantified by Qubit fluorometric quantitation (Thermo Fisher). The integrity of the extracted DNA was evaluated on 0.6% agarose gel. Quantification of 5-methylcytosine was performed using a 5-mC DNA Elisa kit, catalog number D5325 (Zymo Research, Irvine, CA, USA) with 100 ng of DNA input in duplicates according to the manufacturer's instructions.

Statistical analysis {#sec019}
--------------------

Parasitological profile of mice represented the animals of the first perfusion, WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 5) and *EBi3*^*-/-*^I (n = 15). All parasitological parameters were analyzed with p \< 0.05, for eggs on intestine the test used was Unpaired T with Welch's correction, we could not found significance. For Eggs on the liver, the test used was Unpaired T with Welch's correction, we found significance of p = 0.0029. For number of parasites per mouse, the test used was Unpaired T with Welch's correction, no significance was found. For number of couples per mouse, the test used was Unpaired T with Welch's correction, no significance was found. For eggs per gram of feces the test used was Unpaired T with Welch's correction, the significance of p \< 0.0001. For number of granulomas, Mann-Whitney test presented significance of p = 0.0001. For granulomas volume, Unpaired T with Welch's correction presented significance of p \< 0.0001.

Expression of TETS and DNMTs in mice liver was analyzed using Kruskal-Wallis test, p\< 0.05. DMNT1 p = 0.0348; DNMT3A p = 0.0008; DNMT3B p = 0.0001; TET1 p = 0.0041; TET2 p = 0.0001 and TET3 p = 0.0001. Isolate analysis of each group also was conducted using Kruskal-Wallis test, p \< 0.05. WTC p \< 0.0001; WTI p\< 0.0001; *EBi3*^*-/-*^C p = 0.0015 and *EBi3*^*-/-*^I p \< 0.0001. These analysis represented the animals of the two perfusions, WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 10) and *EBi3*^*-/-*^I (n = 28).

Spearman correlation was used in matrix and in dual correlations, the results represented the animals of the first perfusion except *EBi3*^*-/-*^C, WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 10) and *EBi3*^*-/-*^I (n = 15), because all parameters were tested for the first perfusion in infected animals. *EBi3*^*-/-*^C was integrated in matrix because control mouse did not contain eggs on liver or intestine or in stool and the parasitological parameters were the only data that we did not obtain on second perfusion. For matrix correlations results, the p-values and coefficients are plotted in a table at supplemental material. Spearman correlation between number of granulomas and expression of TET3 were significant p = 0.0415, and also spearman correlation between number of granulomas and expression of DNMT1 p \< 0.0001.

Anova one-way test analyzed the differences among treatments considering the expression of genes in *S*. *mansoni*, p \< 0.01. The following genes were significant, *SmGCN5* p = 0.0084; *SmUSP7* p \< 0.0001; *SmUSP22* p \< 0.0001; *SmUSP46* p = 0.0087; *SmHDAC1* p = 0.0002; SmHDAC8 p = 0.0027; and *SmMBD* p \< 0.0001.

*S*. *mansoni* miRNAs expression were significant to miR-190-3p (p = 0.0055) and 5p (p = 0.0033), using Unpaired T with Welch's correction, p \< 0.01. Expression of liver miRNAs was analyzed Mann--Whitney U tests, p \< 0.05. These analysis represented the animals of the two perfusions, WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 10) and *EBi3*^*-/-*^I (n = 28).

Percentages of 5-mC DNA of liver mice samples represented the animals of the first perfusion, WTC (n = 12), WTI (n = 10), *EBi3*^*-/-*^C (n = 5) and *EBi3*^*-/-*^I (n = 15). Anova one-way test was performed, p \< 0.05, the significance of results valued p = 0.0004.

List of accession numbers/ID numbers for genes and proteins mentioned in the text {#sec020}
---------------------------------------------------------------------------------

Gene sequences accessible on GenBank: NC_000086.7 *MmuHPRT;* NC_000075.6 *MmuDNMT1;* NC_000078.6 *MmuDNMT3A;* NC_000068.7 *MmuDNMT3B;* NC_000076.6 *MmuTET1;* NC_000069.6 *MmuTET2;* NC_000072.6 *MmuTET3;* NC_000083.6 Rnu6.

Gene sequences accessible on GeneDB: Smp_070190 *SmGCN5;* Smp_005210 *SmHDAC1;* Smp_093280 *SmHDAC3;* Smp_091990 *SmHDAC8;* Smp_089180 *SmUSP 7;* Smp_128770 *SmUSP 15;* Smp_074400 *SmUSP 22;* Smp_000710 *SmUSP 46;* Smp_123630 *SmUSP 49/44;* Smp_138180 *SmMBD*; Smp_001500 *SmEIF4E*.

LncRNAs transcript ID: TCONS_00001011; TCONS_00012347; TCONS_00013257; TCONS_00003004; TCONS_00000625; TCONS_00001840; TCONS_00009100; TCONS_00009852; TCONS_00009849; TCONS_00009851; TCONS_00012478; TCONS_00010393; TCONS_00010903; TCONS_00011021; TCONS_00013835.

MicroRNAs accessible on miRBase, *S*. *mansoni* miRNAs: MI0021819 miR-190-3p and miR-190-5p; MI0010676 miR-125A and miR-125-3p; MI0021818 miR-124-3p. Mice miRNAs: MI0000579 miR-31-3p and miR-31-5p; MI0000256 miR-122-3p and miR-122-5p.

Supporting information {#sec021}
======================

###### Appearance of granulomas in livers of wild-type and knockout mice.

**(A)** Wild-type uninfected; **(B)** *EBi3*^*-/-*^ uninfected; **(C)** wild-type infected; **(D)** *EBi3*^*-/-*^ infected. Slides prepared after 55 days of infection; livers were fixed in 10%formaldehyde and stained using Hematoxylin eosin.

(TIF)

###### 

Click here for additional data file.

###### Comparison between methylation and demethylation.

**(A)** WTC; **(B)** WTI; **(C)** *EBi3*^*-/-*^C; **(D)** *EBi3*^*-/-*^I. *HPRT* was used as constitutive gene control. Kruskal--Wallis, p \< 0.05; GraphPad Prism6. Comparisons indicated by the following letters are significant. a: *DNMT1* vs. *DNMT3A*; b: *DNMT1* vs. *DNMT3B*; c: *DNMT1* vs. *TET1*; d: *DNMT1* vs. *TET2*; e: *DNMT1* vs. *TET3*; f: *DNMT3A* vs. *DNMT3B*; g: *DNMT3A* vs. *TET1*; H: *DNMT3A* vs. *TET2*; i: *DNMT3A* vs. *TET3*; j: *DNMT3B* vs. *TET1*; k: *DNMT3B* vs. *TET2*; L: *DNMT3B* vs. *TET3*; m: *TET1* vs. *TET2*; n: *TET1* vs. *TET3*; *TET2* vs. *TET3*. Error bars show the standard deviation.

(TIF)

###### 

Click here for additional data file.

###### Expression levels of USP genes *15* and *49/44* and *HDAC3* in *S*. *mansoni*.

Female and male LE represent parasites recovered from WT mice; female and male *EBi3*^*-/-*^ represent parasites recovered from knockout mice; all mice were infected with 100 cercariae. Experiments were done in triplicate using pools of at least 50 parasites per extraction. One-way ANOVA, p \< 0.01; GraphPad Prism 6. No alterations in the expression levels of these genes were observed among the groups under our experimental conditions. Error bars show the standard deviation.

(TIF)

###### 

Click here for additional data file.

###### Correlation matrix: Several parameters in the same infected mice are correlated among themselves.

Spearman correlation, p \< 0.05.

(XLSX)

###### 

Click here for additional data file.

We would like to thank Olinda Mara Brigato and Wander Cosme Ribeiro da Silva for assisting in caring for the mice.
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25 Oct 2019

Dear Dr Sa:

Thank you very much for submitting your manuscript \"Epigenetic and parasitological parameters are modulated in EBi3-/- mice infected with Schistosoma mansoni\" (\#PNTD-D-19-01459) for review by PLOS Neglected Tropical Diseases. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the manuscript as it currently stands. These issues must be addressed before we would be willing to consider a revised version of your study. We cannot, of course, promise publication at that time.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

When you are ready to resubmit, please be prepared to upload the following:

\(1\) A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

\(2\) Two versions of the manuscript: one with either highlights or tracked changes denoting where the text has been changed (uploaded as a \"Revised Article with Changes Highlighted\" file); the other a clean version (uploaded as the article file).

\(3\) If available, a striking still image (a new image if one is available or an existing one from within your manuscript). If your manuscript is accepted for publication, this image may be featured on our website. Images should ideally be high resolution, eye-catching, single panel images; where one is available, please use \'add file\' at the time of resubmission and select \'striking image\' as the file type.

Please provide a short caption, including credits, uploaded as a separate \"Other\" file. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License at <http://journals.plos.org/plosntds/s/content-license> (NOTE: we cannot publish copyrighted images).

\(4\) If applicable, we encourage you to add a list of accession numbers/ID numbers for genes and proteins mentioned in the text (these should be listed as a paragraph at the end of the manuscript). You can supply accession numbers for any database, so long as the database is publicly accessible and stable. Examples include LocusLink and SwissProt.

\(5\) To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see <http://journals.plos.org/plosntds/s/submission-guidelines#loc-methods>

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/> PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

We hope to receive your revised manuscript by Dec 24 2019 11:59PM. If you anticipate any delay in its return, we ask that you let us know the expected resubmission date by replying to this email.

To submit a revision, go to <https://www.editorialmanager.com/pntd/> and log in as an Author. You will see a menu item call Submission Needing Revision. You will find your submission record there.

Sincerely,

Jennifer A. Downs, M.D., Ph.D.

Guest Editor

PLOS Neglected Tropical Diseases

Timothy Geary

Deputy Editor

PLOS Neglected Tropical Diseases

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer\'s Responses to Questions

**Key Review Criteria Required for Acceptance?**

As you describe the new analyses required for acceptance, please consider the following:

**Methods**

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer \#1: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

The hypothesis is stated but should be made more clear.

-Is the study design appropriate to address the stated objectives?

yes

-Is the population clearly described and appropriate for the hypothesis being tested?

yes

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

yes

-Were correct statistical analysis used to support conclusions?

yes

-Are there concerns about ethical or regulatory requirements being met?

yes

Reviewer \#2: The study design to address the stated objectives is poorly described. In particular the number of control mice (WTC, EBi3-/-C) and the number of infected mice (WTI and EBi3-/-I) used in this study is not specified, as well as the sex and age of the animals. A single infection experiment was performed in mice?

The RNA for RT-qPCR studies is prepared from pooled samples. It is not specified the number of mice used for the preparation of RNA. Regarding the correlation studies the statistical significance of the data should be also indicated in the Figure Legends.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Results**

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer \#1: -Does the analysis presented match the analysis plan?

yes, but the results are difficult to follow

-Are the results clearly and completely presented?

there are parts missing and presentation should be made clearer

-Are the figures (Tables, Images) of sufficient quality for clarity?

must be improved

Reviewer \#2: The text of the Results section is poorly presented. It could be helpful for readers to be guided in the list of genes that have been studied: i.e. criteria of selection, relevance. A more focused presentation on the most relevant gene expression variations could improve the quality of the manuscript. Maybe some data could be moved to the Supplemental data section.

Specific comments:

1\. The data presented in Figure 1 are very interesting. The following information are not indicated: the numbers of control and infected mice used for the assessment of parasitological parameters; the number of independent infection experiments eventually performed; the sex and age of the mice used These informations should be included in Figure Legend and in the Experimental section.

2\. Changes in de novo DNA methytransferase and DNA demethylase expression in

EBi3-/- linked to S. mansoni infection. Please specify that the analysis has been made on liver in the title. The significance is Kruskal--Wallis, p \< 0.05 for all letters indicated? What each point represents?

Please indicate in the caption with kind of significance in the correlation has been observed. Spearman correlations: please describe better the parameters that you are correlating: granuloma volume as stated in legend or granuloma number as indicated in (G) and (H). Please specify in Figure 2 caption, which value of significance in the correlation has been detected.

3\. Please indicate in each Figure legend what each point represents (sample/mouse/technical replicate/biological replicate.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Conclusions**

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer \#1: -Are the conclusions supported by the data presented?

yes. But presentation and logics could be improved

-Are the limitations of analysis clearly described?

no

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

yes

-Is public health relevance addressed?

implicitly

Reviewer \#2: The manuscript lack Conclusions and the authors do no discuss how these data can be used for further investigation on the role of the host immune system on schistosomiasis.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Editorial and Data Presentation Modifications?**

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend "Minor Revision" or "Accept".

Reviewer \#1: (No Response)

Reviewer \#2: Dear Editor,

In my opinion this manuscript needs a major revision. There are some interesting results but these are poorly presented.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Summary and General Comments**

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer \#1: Motta et al. describe a very interesting phenomenon and the subject is definitely worth publishing. However, the matter of mutual influences of epigenetic information is complex and the manuscript was in this regard a bit difficult to follow. Essentially, I was often lost in my understanding if the authors talk about Schistosoma or mouse gene expression, RNA presence, modifications of DNA methylation etc.

Please make sure that the reader always knows where he is (in the parasite or in the host) and what the origin of the molecular is (parasite or host). This applies also to the discussion. Please do an effort to make clear where we are and who we talk about, and differentiate it also from the general case/assumption (e.g. line 367 I suppose it is meant that "in general HDAC8 shows nuclear and cytoplasmic location\..."

DNA methylation is used equivalent to 5-methyl-cytosine, but there are more methylation modifications than this. Make this clear from the beginning or change terminology.

I find "epigene" a bit strange and it took me a while to understand that genes coding for chromatin modifying enzymes and chromatin associated RNA is meant.

I recommend that these general points and the specific points below should be addressed by the authors before further review.

Specific comments

Line 19: "genomic imprinting" is a reserved term for imprinted genes. Don't use it in your context.

Line 21: "could occur" since it's a hypothesis

In abstract and author summary explain what epigenetics (and stick to this definition throughout the manuscript) is and why it was investigated. Develop in more detail in the introduction.

Line 82: not clear why there is a link between sentence finishing by "\...adaptation to the host." and the next one "Among other factors\..."

Line 87: "insert" should read "influence"?

Line 103: don't use "imprinting"

Line 104-105: don't understand the sentence

Line 108: mention here which are the parasitic parameters that change

Line 149: in which tissue?

Line 180: talking about demethylating enzyme activity or 5mC level?

Line 196: 0.5% of what?

Line 194-202: good to know that the increase is statistically significant but what is the extent? Fold change or % difference with SD

Line 292: should this read "BUT induction of Th2\..."?

Line 302: should "due to" read "judging from" or similar?

Line 317-330: I don't get the point the authors want to put forward here.

Line 377: should read "...for the methylation and demethylation in the host(?),..." but then why methylation AND demethylation?

Line 380: the figure is not well drawn and as confusing as some parts of the manuscript. It is not clear what is host and what is parasite. Maybe colour code this and make the figure legend more clear.

Reviewer \#2: The authors used C57BL/6 and C57BL/6 EBi3-/- murine (Mus musculus) models of S. mansoni infection in order to investigate possible changes in new and maintenance DNA methylation profiles in the liver after 55 days of infection. Moreover, the authors evaluated the expression levels of epigenetic genes and genes linked to histone deubiquitination in male and female S. mansoni worms by RT-qPCR. The subject is novel and of significance in the Schistosomiasis field and in particular in the host-parasite interplay.

The data are poorly presented but the Manuscript can be improved. The most relevant findings should be highlighted. Importantly, the criteria used for the selection of genes to be investigated are not clearly presented. In the introduction an overview of the genes investigated in the paper should be included. Some information that are in the discussion section should be in the introduction to better follow the data presented in the Results section. The paper lack any Conclusion.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosntds/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Christoph Grunau

Reviewer \#2: No

10.1371/journal.pntd.0008080.r002

Author response to Decision Letter 0

29 Dec 2019

###### 

Submitted filename: Response to Reviwers.docx

###### 

Click here for additional data file.
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22 Jan 2020

Dear Dr Guerra-Sá,

We are pleased to inform you that your manuscript \'Epigenetic and parasitological parameters are modulated in EBi3-/- mice infected with Schistosoma mansoni\' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch within two working days with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Jennifer A. Downs, M.D., Ph.D.

Guest Editor

PLOS Neglected Tropical Diseases

Timothy Geary

Deputy Editor

PLOS Neglected Tropical Diseases

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer\'s Responses to Questions

**Key Review Criteria Required for Acceptance?**

As you describe the new analyses required for acceptance, please consider the following:

**Methods**

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer \#2: YES

The manuscript has been revised accordingly to the reviewers\' comments

\*\*\*\*\*\*\*\*\*\*

**Results**

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer \#2: YES

The manuscript has been revised accordingly to the reviewers\' comments

\*\*\*\*\*\*\*\*\*\*

**Conclusions**

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer \#2: YES

The manuscript has been revised accordingly to the reviewers\' comments

\*\*\*\*\*\*\*\*\*\*

**Editorial and Data Presentation Modifications?**

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend "Minor Revision" or "Accept".

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

**Summary and General Comments**

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer \#2: The manuscript has been revised accordingly to the reviewers\' comments.

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosntds/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

10.1371/journal.pntd.0008080.r004
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11 Feb 2020

Dear Dr Guerra-Sá,

We are delighted to inform you that your manuscript, \"Epigenetic and parasitological parameters are modulated in EBi3-/- mice infected with Schistosoma mansoni,\" has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc\...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Serap Aksoy

Editor-in-Chief

PLOS Neglected Tropical Diseases

Shaden Kamhawi

Editor-in-Chief

PLOS Neglected Tropical Diseases
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